维普期刊资源整合服务平台（V6.5）

23篇 您的检索式：作者名="Moise PA"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Pharmacokinetics and metabolism of moxifloxacin 显示文摘	Moise PA Birmingham MC Schentag JJ	2000	Drugs of Today2000，36，4：	1
2	Microbiological effects of prior vancomycin use in patients with methieil- lin-resistant Staphylococcusaureus bacteremia 显示文摘	Moise PA Smyth DS E1-Fawal N	2008	J Anti- microb Chemother2008，61，1：	1
3	Phannaeokineties and metabolism of moxifloxacin显示文摘	Moise PA Birmingham MC Schentag JJ	2000	Drugs of Today2000，36，4：	1
4	The efficacy and safety of linezolid as treatment for Staphylococcus aureus infectionsin compassionate use patients who are intolerant of, or who have failed to respond to, vancomycin 显示文摘	Moise PA Forrest A Birmingham MC	2002	J Antimicrob Chemother2002，50，：	1
5	Vancomycin treatment failures in Staphylococcus aureus lower respiratory tract infections 显示文摘	Moise PA Schentag JJ	2000	Int J Antimicrob Agents2000，16，1：	1
6	Vancomycin treatment failures in Staphylococcus aureus lower respiratory tract infections显示文摘	Moise PA Schentag JJ	2000	Int J Antimicrob Agents2000，16，1：	1
7	Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia显示文摘	Moise PA Sakoulas G Forrest A	2007	Antimicrob Agents Chemother2007，51，7：	1
8	Phannaeokineties and metabolism of moxifloxacin显示文摘	Moise PA Birmingham MC Schentag JJ	2000	Drugs of Today2000，36，4：	1
9	Reduced susceptibility to host-defense cationic peptides and daptomycin coemerge in me- thicillin-resistant Staphylococcus aureus from daptomycin-naive bacteremic patients 显示文摘	Mishra NN Bayer AS Moise PA	2012	J Infect Dis2012，206，8：	1
10	Pharmacokineticsand Metabolism of Moxifloxacin显示文摘	Birmingham MC Schentag JJ	2000	Drugs of Today2000，36，4：	1
11	Vancomycin invitro bactericidal activity and its relationship to efficacy inclearance of methicillin-resistant Staphylococcus aureus bac-teremia显示文摘	Moise PA Sakoulas G Forrest A	2007	J Antimicrob Agents Chemother2007，51，7：	1
12	Microbiological effects of priorvan- comycin use in patients with methicillin-resistant Staphylococcus aureus bacteraemia显示文摘	Moise PA Smyth DS El-Fawal N	2008	Antimicrob Chemother2008，61，10：	1
13	Vancomycint reatment failures in Staphylococcus aureus lower respiratory tract infections 显示文摘	Moise PA Schentag JJ	2000	Int J Antimicrob Agents2000，16，1：	1
14	Area under the inhibitory curve and a pneumonia scoring system for predicting outcomes of vancomycin therapy for respiratory infectionsby Staphylococcus aureus显示文摘	Moise PA Forrest A Blavnani SM	2000	Am J Health Syst Pharm2000，57，2：	1
15	Pharmacokinetics and metabolism of moxifloxacin 显示文摘	Moise PA Birmingham MC Schentag JJ	2000	Drugs Today ( Barc )2000，36，4：	1
16	Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant staphylococcus aureus bacteremia显示文摘	SAKOULAS G PAMELA A MOISE BRODRE PA	2004	J Clin Microbiol2004，42，24：	1
17	Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia显示文摘	Moise PA Sakoulas G Forrest A	2007	Antimicrob Agents Chemother2007，51，：	1
18	Pharmaeokineties and metabolism of moxifloxacin 显示文摘	Moise PA Birmingham MC Sehentag JJ	2000	Drugs Today (Barcelona Spain~ 1998)2000，36，4：	1
19	Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections显示文摘	MOISE PA FORREST A BIRMINGHAM MC	2004	Clin Pharmacokinet2004，43，13：	1
20	The efficacy andsafety of linezolid as treatment for Staphylococcus aureus infec-tions in compassionate use patients who are intolerant of,orwho have failed to respond to,vancomycin显示文摘	Moise PA Forrest A Birmingham MC	2002	J AntimicrobChemother2002，50，6：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示